Tagged with Thomas Ve

New research has successfully switched off a key pathway of nerve fibre breakdown in debilitating neurodegenerative disorders

Scientists have visualised and investigated a key molecular pathway that could one day help treat inflammation, diabetes, cancer, infectious diseases and potentially even COVID-19.

A Griffith University-led research team has discovered how a therapeutic target common among debilitating neurodegenerative disorders is activated, which could help accelerate drug development.

Structural biologist Dr Thomas Ve from the Institute for Glycomics has been awarded an Australian Research Council Future Fellowship.

Four Griffith University researchers have been awarded Australian Research Council (ARC) Future Fellowships worth more than $3.8 million.

The Institute for Glycomics has been awarded two National Health and Medical Research Council Investigator Grants.